Scholars Central

Conference abstractPublished 26 Oct 2015

Leptospirosis vaccines: Current view

Authors: Satish K Srivastava

Indian Veterinary Research Institute, India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Leptospirosis has in recent years emerged as one of the priority diseases in the country as it is responsible for substantial economic losses to the farmers as a result of various reproductive disorders it causes in animals such as abortions, still birth and repeat breeding including mastitis and agalactia. Research on the development of a suitable vaccine for control of the disease has continued since last 50 years with mixed findings. Presently we have inactivated whole cell vaccines which comprise of one or preferably several Leptospira serovars with or without adjuvant to provide a broad range of immunity. Selection of serovars in preparing these vaccines depends on the prevalence of the serovars in the target area or animal population. Repeated vaccinations are required to generate protective immunity in animals which may not last for more than 6 months. A few such multivalent killed commercial vaccines are currently in use in countries such as USA, Australia, New Zealand and UK. Due to short lived immunity generated by these vaccines, development of live vaccines was attempted using highly prevalent serovars, Pomona and icterohaemorrhagiae. Though these vaccines generated higher level of immunity in animals, however, the problem of maintenance of the vaccine strains and reversion to the virulent form have been the constraints in their wider acceptability. Subunit vaccines prepared from surface proteins separated from outer cell membrane have been a much accepted option. A few protein sub units targeted for such studies are 39 kDa, Omp L1, Lip41, LipL32 and Lig proteins. Efforts on the expression of some of these proteins for vaccination have been partly successful. Latest approaches for vaccination include use of DNA construct using flaB2 gene and outer membrane protein genes of serovar Lai and Hap1/LipL32 gene of serovar autumnalis or Grippotyphosa. Studies on the improvements in the existing vaccines and development of new generation vaccines are continuing.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Veterinary Science & Technology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalVeterinary Science & Technology
  • SubjectVeterinary & Animal Science
  • BylineArticles whose byline prints “Satish K Srivastava”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels